Here’s why a Md. firm is buying a smallpox vaccine business for $125M

A Maryland life sciences company is acquiring a smallpox vaccine business from a French drug company in a deal worth up to $125 million. Emergent BioSolutions Inc., of Gaithersburg, has agreed to buy the Acam2000 smallpox vaccine business from Sanofi in a cash deal, with $97.5 million paid up front and as much as $27.5 million ...

To purchase a reprint of this article, contact reprints@thedailyrecord.com.

Leave a Reply

Your email address will not be published. Required fields are marked *